27 April 2021

As producers of the essential building blocks used to make medicines, EFCG welcomes the Commission’s initiative to ensure a future-proof and crisis-resistant medicines regulatory system that will allow all EU citizens full and equal access to safe, state-of-the-art therapies.
This document summarises our recommendations for the four pillars of the forthcoming EU Pharmaceutical strategy.